Concerning IBD, it was reported that FNDC4 is upregulated in the mucosa and acts as an anti-inflammatory factor via the downregulation of proinflammatory genes and phagocytosis [1]. This evidence concerns the gene FNDC4 and inflammatory bowel disease.